Foreign Investors Trigger ‘Critical Technology' Review for Biotech
Source: Life Science Leader
By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton
U.S. biotech companies that receive foreign investments and are developing critical technologies or the components that enable those technologies now might have to file mandatory declarations with the Committee on Foreign Investment in the U.S. (CFIUS). The new rules apply to investors from any foreign country — and apply even if the investor does not take a controlling interest in the company.
VIEW THE MAGAZINE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader X
Subscribe to Life Science Leader